Abstract
43P - Mir31-3P Expression in Patients with Advanced Lepidic Adenocarcinoma (L-ADC) Treated with EGFR Tki in Ifct 0401 and 0504 Trials
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1093/annonc/mdv045.07
Copy DOIJournal: Annals of Oncology | Publication Date: Apr 1, 2015 |
License type: publisher-specific-oa |
43P - Mir31-3P Expression in Patients with Advanced Lepidic Adenocarcinoma (L-ADC) Treated with EGFR Tki in Ifct 0401 and 0504 Trials
Join us for a 30 min session where you can share your feedback and ask us any queries you have